CASE SERIES OF METAPLASTIC CARCINOMA OF BREAST IN A TERTIARY CARE CENTER OF ROHILKHAND REGION

Main Article Content

Swasti Garg
Subhra Kumari
Nidhi Johri
Surabhi Pandey
Tanu Agrawal

Keywords

Metaplastic carcinoma; cancer; mesenchymal differentiation; spindle cell differentiation; mixed metaplastic breast carcinom

Abstract

Metaplastic carcinoma of breast is a rare, high-grade subtype of invasive breast carcinoma, accounting for less than 1% of all breast malignancies. It is characterized by a heterogeneous composition of both epithelial and mesenchymal elements and is typically triple-negative for hormonal receptors, making its management particularly challenging.


 


Aim: We aimed to describe the clinicopathological characteristics of metaplastic carcinoma of breast diagnosed over a two-year period at the Department of Pathology, SRMS IMS, with a focus on histological subtypes and immunohistochemical (IHC) patterns.


 


Methods: This retrospective observational case series was conducted in the Department of Pathology, SRMS IMS, Bareilly, after approval from the Institutional Ethics Committee. Seven histologically confirmed cases of Metaplastic carcinoma were included. Clinical data, histopathological features, and IHC profiles were reviewed from departmental archives. All patients provided informed consent. Parameters evaluated included age, tumour laterality, size, histological differentiation, and IHC markers (ER, PR, HER2/neu, PanCK, P63, SMA, CK7, and P40, P63, Vimentin). Descriptive analysis was performed. No formal statistical test was applied due to the limited sample size.


 


Results: All patients were female, with ages ranging from 35 to 58 years (mean: 48 years). Right-sided involvement was more common. Tumour sizes ranged from 10 cm to 30 cm. Spindle cell was the predominant histologic pattern (3 cases) followed by Heterologous Mesenchymal differentiation, Squamous Cell, Low Grade Adenosquamous, Mixed Metaplastic Carcinoma (1 each).


 


Conclusion: Metaplastic carcinoma is a morphologically diverse, aggressive neoplasm requiring accurate histopathological subtyping and IHC correlation for diagnosis.

Abstract 211 | PDF Downloads 33

References

1. Luini A, Aguilar M, Gatti G, Fasani R, Botteri E, Brito JA, et al. Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat. 2007 Mar;101:349–53.
2. Pezzi CM, Patel-Parekh L, Cole K, Franko J, Klimberg VS, Bland K. Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base. Ann Surg Oncol. 2007 Jan;14:166–73.
3. Schwartz TL, Mogal H, Papageorgiou C, Veerapong J, Hsueh EC. Metaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies. Exp Hematol Oncol. 2013 Dec;2:1–6.
4. Tavassoli FA. Classification of metaplastic carcinomas of the breast. Pathol Annu. 1992;27(Pt 2):89–119.
5. Rayson D, Adjei AA, Suman VJ, Wold LE, Ingle JN. Metaplastic breast cancer: prognosis and response to systemic therapy. Ann Oncol. 1999;10(4):413–9.
6. Al Sayed AD, El Weshi AN, Tulbah AM, et al. Metaplastic carcinoma of the breast: clinical presentation, treatment results and prognostic factors. Acta Oncol. 2006;45:188–95.
7. Tavassoli FA. Classification of metaplastic carcinomas of the breast. Pathol Annu. 1992;27(Pt 2):89–119.
8. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. Hum Pathol. 1989;20:628–35.
9. Wargotz ES, Deos PH, Norris HJ. Metaplastic carcinomas of the breast. II. Spindle cell carcinoma. Hum Pathol. 1989;20:732–40.
10. Gutman H, Pollock RE, Janjan NA, et al. Biologic distinctions and therapeutic implications of sarcomatoid metaplasia of epithelial carcinoma of the breast. J Am Coll Surg. 1995;180:193–9.
11. Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. III. Carcinosarcoma. Cancer. 1989;64:1490–9.
12. Carter CL, Allen C, Henson DE. Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer. 1969;63:181–7.
13. Böler DE, Kara H, Sağlıcan Y, Tokat F, Uras C, et al. Metaplastic carcinoma of the breast: a case series and review of the literature.